Silver Book

Silver Book Fact

Drug resistant infections cost $16.6 – $26 billion to US healthcare system annually

Drug-resistant infections cost the U.S. healthcare system between $16.6 and $26 billion in extra costs each year.

Rboerts R, Hota B, Ahmad I, Scott R, et al. Hospital and Societal Costs of Antimicrobial-Resistant Infections in a Chicago Teaching Hospital: Implicatons for antibiotic stewardship. Clin Infect Dis. 2009; 49(8): 1175-84. http://cid.oxfordjournals.org/content/49/8/1175.full

Reference

Title
Hospital and Societal Costs of Antimicrobial-Resistant Infections in a Chicago Teaching Hospital: Implicatons for antibiotic stewardship
Publication
Clin Infect Dis
Publication Date
2009
Authors
Rboerts R, Hota B, Ahmad I, Scott R, et al.
Volume & Issue
Volume 49, Issue 8
Pages
1175-84
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Publications

Healthcare-Associated Infections Factsheet

 https://www.silverbook.org/wp-content/uploads/2015/06/Screen-Shot-2015-06-30-at-3.02.28-PM.png Thumbnail

Related Facts

  • Hospital stays longer when HAIs involved
    The average length of hospital stays are 19 days longer with healthcare-associated infections than without (24.4 days versus 5.2 days).  
  • Comorbidities and hospitalization higher with HAIs
    Patients with HAIs have more comorbidities (2.8 vs. 1.9) and in-hospital mortality (9% vs. 1.5%), compared to all other hospitalized patients.  
  • HAI Annual Cost
    Healthcare-associated infections in US hospitals cost $96–$147 billion annually.  
  • Significant increase of penicillin-resistant Streptococcus penumoniae
    High-level penicillin-resistant Steptococcus pneumoniae increased 1,000-fold over 17 years.  
  • Patients hospitalized for sepsis experience poor outcomes
    Compared with patients hospitalized with other diagnoses, patients hospitalized for sepsis/septicemia are: 1/2 as likely to be discharged home 2 times more likely to be discharged to other short-term care 3 times more…